These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 26278014

  • 1. Predictors of intrahepatic cholangiocarcinoma in cirrhotic patients scanned by gadobenate dimeglumine-enhanced magnetic resonance imaging: diagnostic accuracy and confidence.
    Quaia E, Angileri R, Arban F, Gennari AG, Cova MA.
    Clin Imaging; 2015; 39(6):1032-8. PubMed ID: 26278014
    [Abstract] [Full Text] [Related]

  • 2. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E, Pizzolato R, De Paoli L, Angileri R, Ukmar M, Cova MA.
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [Abstract] [Full Text] [Related]

  • 3. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
    Jeon TY, Kim SH, Lee WJ, Lim HK.
    Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
    [Abstract] [Full Text] [Related]

  • 4. Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.
    Piscaglia F, Iavarone M, Galassi M, Vavassori S, Renzulli M, Forzenigo LV, Granito A, Salvatore V, Sangiovanni A, Golfieri R, Colombo M, Bolondi L.
    Dig Dis; 2015 Oct; 33(6):735-44. PubMed ID: 26488875
    [Abstract] [Full Text] [Related]

  • 5. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.
    Mamone G, Marrone G, Caruso S, Carollo V, Gentile G, Crino' F, Milazzo M, Luca A.
    Abdom Imaging; 2015 Oct; 40(7):2313-22. PubMed ID: 25962708
    [Abstract] [Full Text] [Related]

  • 6. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.
    Dioguardi Burgio M, Picone D, Cabibbo G, Midiri M, Lagalla R, Brancatelli G.
    Abdom Radiol (NY); 2016 Aug; 41(8):1546-54. PubMed ID: 27052455
    [Abstract] [Full Text] [Related]

  • 7. Predictors of dysplastic nodule diagnosis in patients with liver cirrhosis on unenhanced and gadobenate dimeglumine-enhanced MRI with dynamic and hepatobiliary phase.
    Quaia E, De Paoli L, Pizzolato R, Angileri R, Pantano E, Degrassi F, Ukmar M, Cova MA.
    AJR Am J Roentgenol; 2013 Mar; 200(3):553-62. PubMed ID: 23436844
    [Abstract] [Full Text] [Related]

  • 8. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
    Hwang J, Kim YK, Park MJ, Lee MH, Kim SH, Lee WJ, Rhim HC.
    J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
    [Abstract] [Full Text] [Related]

  • 9. Gadobenate dimeglumine-enhanced liver magnetic resonance imaging: value of hepatobiliary phase for the detection of focal liver lesions.
    Fu GL, Du Y, Zee CS, Yang HF, Li Y, Duan RG, Zeng NL, Xiao DM.
    J Comput Assist Tomogr; 2012 Oct; 36(1):14-9. PubMed ID: 22261765
    [Abstract] [Full Text] [Related]

  • 10. A Ring in the Liver.
    Xu J, Liang X, Cai X.
    Am J Gastroenterol; 2021 Jan 01; 116(1):220-222. PubMed ID: 32868632
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma.
    Kim TK, Lee KH, Jang HJ, Haider MA, Jacks LM, Menezes RJ, Park SH, Yazdi L, Sherman M, Khalili K.
    Radiology; 2011 Jun 01; 259(3):730-8. PubMed ID: 21364083
    [Abstract] [Full Text] [Related]

  • 12. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M.
    Zheng W, Huang H, She D, Xiong M, Chen X, Lin X, Cao D.
    Abdom Radiol (NY); 2022 Mar 01; 47(3):957-968. PubMed ID: 34964069
    [Abstract] [Full Text] [Related]

  • 13. Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
    Shetty AS, Fowler KJ, Brunt EM, Agarwal S, Narra VR, Menias CO.
    Abdom Imaging; 2014 Apr 01; 39(2):310-22. PubMed ID: 24407728
    [Abstract] [Full Text] [Related]

  • 14. Effect of increasing the flip angle during the hepatocyte phase of gadobenate dimeglumine-enhanced 1.5T MRI in cirrhotic patients with hepatocellular carcinoma.
    Lee EJ, Kim DJ, Cho ES, Kim KA.
    J Magn Reson Imaging; 2016 Mar 01; 43(3):713-9. PubMed ID: 26290384
    [Abstract] [Full Text] [Related]

  • 15. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
    Péporté AR, Sommer WH, Nikolaou K, Reiser MF, Zech CJ.
    Eur J Radiol; 2013 Mar 01; 82(3):e101-6. PubMed ID: 23159401
    [Abstract] [Full Text] [Related]

  • 16. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
    Dong Y, Chen S, Möller K, Qiu YJ, Lu XY, Zhang Q, Dietrich CF, Wang WP.
    Ultrasound Med Biol; 2023 Aug 01; 49(8):1780-1788. PubMed ID: 37156676
    [Abstract] [Full Text] [Related]

  • 17. Incorporating the hepatobiliary phase of gadobenate dimeglumine-enhanced MRI in the diagnosis of hepatocellular carcinoma: increasing the sensitivity without compromising specificity.
    Cortis K, Liotta R, Miraglia R, Caruso S, Tuzzolino F, Luca A.
    Acta Radiol; 2016 Aug 01; 57(8):923-31. PubMed ID: 26567965
    [Abstract] [Full Text] [Related]

  • 18. Comparison of portal venous and delayed phases of gadolinium-enhanced magnetic resonance imaging study of cirrhotic liver for the detection of contrast washout of hypervascular hepatocellular carcinoma.
    Cereser L, Furlan A, Bagatto D, Girometti R, Como G, Avellini C, Orsaria M, Zuiani C, Bazzocchi M.
    J Comput Assist Tomogr; 2010 Aug 01; 34(5):706-11. PubMed ID: 20861773
    [Abstract] [Full Text] [Related]

  • 19. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
    Maetani Y, Itoh K, Watanabe C, Shibata T, Ametani F, Yamabe H, Konishi J.
    AJR Am J Roentgenol; 2001 Jun 01; 176(6):1499-507. PubMed ID: 11373220
    [Abstract] [Full Text] [Related]

  • 20. MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.
    Sheng RF, Xie YH, Ji Y, Chen CZ, Yang L, Jin KP, Zeng MS.
    Abdom Radiol (NY); 2016 Nov 01; 41(11):2102-2114. PubMed ID: 27315077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.